Agency: Merck Pharm
Agency Award Number: 33132
This project will estimate the penetration of Raltegravir into the brain by
measuring its concentrations in CSF and estimate the antiviral effectiveness
in the brain of Raltegravir by measuring HIV RNA levels in CSF.
